IFM Therapeutics, Inc. — Form D
IFM Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-28. $17.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-06-28
- Form: D
- Accession: 0001678359-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $17.1M
- Investors: 4
- Date of first sale: 2016-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-265896
Issuer
- Name: IFM Therapeutics, Inc.
- CIK: 0001678359
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 400 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139
- Phone: 857-201-2794
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Jean-Francois Formela | Director | Cambridge, MA |
| Gary Glick | Director | LONDON, X0 |
| Gary Glick | Executive Officer | LONDON, X0 |
More